GeoVax Labs Inc reports results for the quarter ended in December - Earnings Summary

Geovax Labs

01/03/2024 17:20

* GeoVax Labs Inc  GOVX.OQ  reported a quarterly adjusted
loss of
$13.60​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of
$-3.00.  The mean expectation of four analysts for the quarter
was for a loss of $2.78 per share. Wall Street expected
results to range from $-5.10 to 7 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * GeoVax Labs Inc's reported EPS for the quarter was a loss
of
$13.60​.
    * The company reported a quarterly loss of $7.59 million.
    * GeoVax Labs Inc shares had fallen by 52.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 33.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for GeoVax Labs Inc
is $90.00 
This summary was machine generated from LSEG data March 1 at
05:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -2.78          -13.60         Missed
 Sep. 30 2023      -3.60          -4.80          Missed
 Jun. 30 2023      -2.47          -3.30          Missed
 Mar. 31 2023      -3.05          -2.25          Beat